Patient-reported outcomes in those consuming medical cannabis: a prospective longitudinal observational study in chronic pain patients.
CONCLUSION: Despite significant challenges to collecting long-term observational data on patients who attempted a trial of cannabis products, approximately one-third of patients in the cohort remained on medical cannabis for six months. In this cohort, pain intensity and pain-related interference scores were reduced and QoL and general health symptoms scores were improved compared with baseline.
PMID: 33469735 [PubMed - as supplied by publisher]
Source: Canadian Journal of Anaesthesia - Category: Anesthesiology Authors: Meng H, Page MG, Ajrawat P, Deshpande A, Samman B, Dominicis M, Ladha KS, Fiorellino J, Huang A, Kotteeswaran Y, McClaren-Blades A, Kotra LP, Clarke H Tags: Can J Anaesth Source Type: research
More News: Anesthesia | Anesthesiology | Anxiety | Brain | Canada Health | Chronic Pain | Depression | Men | Neurology | Pain | Study